Bicara Therapeutics Inc. ($BCAX)
Filing Information
| Accession Number | 0001470831-26-000814 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 12, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
37,500
Total Value
$396,963.75
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Aug 10, 2026 | Exercise/Conversion | 12,500 | $3.79 | $47,372.50 | 142,355 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Aug 10, 2026 | Sale | 12,500 | $27.97 | $349,591.25 | 129,855 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Aug 10, 2026 | Exercise/Conversion | 12,500 | $0.00 | $0.00 | 26,336 | Direct | โ | View Details |